脉冲磁疗系统在失眠障碍中的有效性和安全性:多中心,随机,双盲,安慰剂控制的试验
Jiwu Liao1, Sisi Wang1, Borong Zhou2
1Department of Psychiatry, Sleep Medicine Centre, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Psychiatry investigation
|June 26, 2023
概括
与虚假治疗相比,脉冲磁疗系统 (PMTS) 显著改善了失眠障碍症状. 这种安全有效的疗法为改善睡眠质量提供了一个有希望的解决方案.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 生物医学工程 生物医学工程
背景情况:
- 失眠障碍是一种普遍的疾病,影响全球数百万人.
- 目前对失眠障碍的治疗有局限性和潜在的副作用.
- 越来越多地寻求非药物干预措施来管理睡眠障碍.
研究的目的:
- 评估脉冲磁疗系统 (PMTS) 对被诊断患有失眠障碍的人的疗效和安全性.
- 将PMTS的治疗结果与假治疗方案进行比较.
主要方法:
- 进行了一项随机对照试验,其中153名参与者被诊断患有失眠障碍.
- 参与者接受了四周的PMTS或假治疗.
- 失眠严重性指数 (ISI) 评分是主要结果,每周和随访时进行评估. 其次结果包括匹兹堡睡眠质量指数 (PSQI) 和睡眠日记指标.
主要成果:
- 与虚假组相比,PMTS组在ISI分数中显示出显著的持续改善.
- 在第4周,PMTS组的ISI分数 (7.13±0.50) 与假装组 (11.07±0.51) 相比,PMTS组的ISI分数明显较低.
- 在PMTS组中,治疗响应率明显高 (4周69.7%,随访75.0%),治疗后效应持续.
结论:
- 脉冲磁疗系统 (PMTS) 在改善失眠障碍方面表现出显著的有效性.
- 对于患有失眠症的人来说,PMTS是一种安全的治疗选择.
- 在治疗期间,PMTS对睡眠质量的积极影响会持续到治疗期间之后.
更多相关视频
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
2.3K
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
396
相关概念视频
01:19Management of Insomnia
283
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
283
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
204
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
204
01:27Insomnia
110
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
110